临床药师干预对改善儿童和青少年哮喘护理的效果：约旦的随机对照研究。

The effectiveness of clinical pharmacist's intervention in improving asthma care in children and adolescents: Randomized controlled study in Jordan.

作者信息

Almomani Basima A, Mayyas Rawan K, Ekteish Faisal Abu, Ayoub Abeer M, Ababneh Mera A, Alzoubi Sirin A

机构信息

Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.

出版信息

Patient Educ Couns. 2017 Apr;100(4):728-735. doi: 10.1016/j.pec.2016.11.002. Epub 2016 Nov 7.

DOI:10.1016/j.pec.2016.11.002

PMID:27839892

Abstract

OBJECTIVE

To evaluate the effectiveness of clinical pharmacist's intervention on achieving better asthma control, quality of life and other clinical parameters.

METHODS

A prospective randomized controlled study in north Jordan was conducted. Pediatric patients with asthma (aged 7-18 years old) were included and randomly allocated into two groups, intervention and control. Both groups were interviewed at the first visit and followed up twice by phone (at 3 and 6 months). Education was provided to patients and their caregivers in the intervention group only.

RESULTS

Of 206 eligible patients recruited and randomized to our study, 178 patients completed the study (48.3% intervention versus 51.7% control). There were no significant differences in all baseline data between both groups. We identified significant differences in the improvement of asthma control (p<0.001) and consequently pediatric and caregiver quality of life (p<0.001) between both groups at the end of study. Significant differences were also detected in other clinical parameters (p<0.05).

CONCLUSION

Implementation of clinical pharmacy service can positively influence asthma control, pediatric and caregiver's quality of life, and other clinical parameters.

PRACTICE IMPLICATIONS

To maintain a good asthma status, education of pediatric patients and their caregivers should be part of routine assessment during clinic visit.

摘要

目的

评估临床药师干预对实现更好的哮喘控制、生活质量及其他临床参数的有效性。

方法

在约旦北部进行了一项前瞻性随机对照研究。纳入7至18岁的哮喘患儿，随机分为两组，即干预组和对照组。两组在首次就诊时均接受访谈，并通过电话随访两次（3个月和6个月时）。仅对干预组的患者及其照顾者进行教育。

结果

在招募并随机分组至本研究的206例符合条件的患者中，178例患者完成了研究（干预组占48.3%，对照组占51.7%）。两组所有基线数据均无显著差异。在研究结束时，我们发现两组在哮喘控制改善方面存在显著差异（p<0.001），因此在儿童及照顾者生活质量方面也存在显著差异（p<0.001）。在其他临床参数方面也检测到显著差异（p<0.05）。